SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-003639
Filing Date
2020-01-14
Accepted
2020-01-14 08:28:18
Documents
4
Period of Report
2020-01-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm203371d1_8k.htm 8-K 16132
2 EXHIBIT 99.1 tm203371d1_ex99-1.htm EX-99.1 25668
3 GRAPHIC tm203371d1_ex99-1img001.jpg GRAPHIC 17519
4 GRAPHIC tm203371d1_ex99-1img002.jpg GRAPHIC 8321
  Complete submission text file 0001104659-20-003639.txt   78951
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filer) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36621 | Film No.: 20525024
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences